A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
PHASE2
Head and neck cancer is the malignant tumor with the highest morbidity and ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer
PHASE2
Preoperative radiotherapy combined with 5-fluorouracil/capecitabine is curr...
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
PHASE3
The purpose of study is to compare bladder intact-event free survival (BI-E...